Jikilani, Sal .
HRN: 26-96-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/17/2025
06/27/2025
PO
5ml
TID
Amoebiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes